Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Indicadores sociales
2
Administración
1
Antropología forense
1
Calidad de vida
1
Capital humano
1
Comportamiento organizacional
1
Comunidades indígenas
1
Condiciones sociales
1
Desarrollo sostenible
1
Educación inclusiva
1
Educación superior
1
Estudiantes con discapacidades
1
Exhumación
1
Filosofía de la tecnología
1
Identificación
1
Liderazgo
1
Minorías
1
Muerte
1
Mujeres
1
Personas desaparecidas
1
Realidad virtual
1
-
1841por Latini, Francesco, Fahlström, Markus, Beháňová, Andrea, Sintorn, Ida-Maria, Hodik, Monika, Staxäng, Karin, Ryttlefors, Mats“…Magnetic resonance imaging of sixty-seven diffuse low-grade gliomas patients were normalized to/and segmented in MNI space to create three probabilistic infiltration weighted gradient maps according to the molecular status of each tumor group (IDH mutated, IDH wild-type and IDH mutated/1p19q co-deleted). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1842por Gómez Vecchio, Tomás, Neimantaite, Alice, Corell, Alba, Bartek, Jiri, Jensdottir, Margret, Reinertsen, Ingerid, Solheim, Ole, Jakola, Asgeir S.“…Eloquent regions are found slightly more frequently in the proximity of IDH-mutated astrocytomas compared to oligodendrogliomas. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1843por Verner, Zdeněk, Žárský, Vojtěch, Le, Tien, Narayanasamy, Ravi Kumar, Rada, Petr, Rozbeský, Daniel, Makki, Abhijith, Belišová, Darja, Hrdý, Ivan, Vancová, Marie, Lender, Corinna, König, Constantin, Bruchhaus, Iris, Tachezy, Jan“…Proteomic analyses of affinity-purified peroxisomes and in silico PTS1 predictions provided datasets of 655 and 56 peroxisomal candidates, respectively; however, only six proteins were shared by both datasets, including myo-inositol dehydrogenase (myo-IDH). Peroxisomal NAD-dependent myo-IDH appeared to be a dimeric enzyme with high affinity to myo-inositol (Km 0.044 mM) and can utilize also scyllo-inositol, D-glucose and D-xylose as substrates. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1844“…Based on the test results, a 25-year-old man with BRAF V600E mutation was initiated into the NCCH1901 study (Patient-Proposed Healthcare Services). A case with IDH1 mutation (47-year-old male) entered a phase I clinical trial of a mutant IDH1 inhibitor. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1845por Kim, Ka Young, Park, Hae Sang, Kim, Jin Sun, Ahn, Shin Young, Ko, Gang Jee, Kwon, Young Joo, Kim, Ji Eun“…BACKGROUND: Intradialytic hypotension (IDH) has been reported to be an important prognostic factor in hemodialysis patients. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1846por Kraus, Theo F. J., Schwartz, Christoph, Machegger, Lukas, Zellinger, Barbara, Hölzl, Dorothee, Schlicker, Hans U., Pöppe, Johannes, Ladisich, Barbara, Spendel, Mathias, Kral, Michael, Sotlar, Karl“…In depth molecular profiling revealed two independent brain tumors with distinct molecular profiles of anaplastic oligodendroglioma IDH mutated 1p/19q co-deleted WHO Grade III and glioblastoma IDH wildtype WHO grade IV. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1847por Kang, Dain, Jung, Jin, Park, Silvia, Cho, Byung-Sik, Kim, Hee-Je, Kim, Yeojae, Lee, Jong-Mi, Kim, Hoon Seok, Ahn, Ari, Kim, Myungshin, Kim, Yonggoo“…Both mutations could be used as surrogate markers to diagnose AML-MRC, especially when the assessment of multilineage dysplasia was difficult. IDH1/IDH2 (n = 13, 29%) were most commonly mutated in AML-MRC, followed by CEBPA (n = 5, 11%), PTPN11 (n = 5, 11%), FLT3 (n = 4, 9%), IDH1 (n = 4, 9%), and RUNX1 (n = 4, 9%). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1848por Corell, Alba, Gómez Vecchio, Tomás, Ferreyra Vega, Sandra, Dénes, Anna, Neimantaite, Alice, Hagerius, Alexander, Barchéus, Hanna, Solheim, Ole, Lindskog, Cecilia, Bontell, Thomas Olsson, Carén, Helena, Jakola, Asgeir S, Smits, Anja“…METHODS: We included 188 patients ≥18 years with IDH-mutated dLGG (WHO grades 2–3) histologically diagnosed between 2007 and 2020. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1849por Li, Xianqi, Strasser, Bernhard, Neuberger, Ulf, Vollmuth, Philipp, Bendszus, Martin, Wick, Wolfgang, Dietrich, Jorg, Batchelor, Tracy T, Cahill, Daniel P, Andronesi, Ovidiu C“…BACKGROUND: Magnetic resonance spectroscopic imaging (MRSI) can be used in glioma patients to map the metabolic alterations associated with IDH1,2 mutations that are central criteria for glioma diagnosis. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1850por Sareen, Heena, Ma, Yafeng, Becker, Therese M., Roberts, Tara L., de Souza, Paul, Powter, Branka“…Five studies including 541 GBM patients analysed for the prognostic significance of IDH1 mutation showed significantly better OS in patients with IDH1 mutation with a pooled HR of 2.37 (95% CI 1.81–3.12; p < 0.00001]. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1851por HIGA, Nayuta, AKAHANE, Toshiaki, YOKOYAMA, Seiya, YONEZAWA, Hajime, UCHIDA, Hiroyuki, FUJIO, Shingo, KIRISHIMA, Mari, TAKIGAWA, Kosuke, HATA, Nobuhiro, TOH, Keita, YAMAMOTO, Junkoh, HANAYA, Ryosuke, TANIMOTO, Akihide, YOSHIMOTO, Koji“…Reclassification based on the WHO 2021 classification resulted in 62.5% of grade II/III isocitrate dehydrogenase (IDH)-wildtype astrocytomas being classified as IDH-wildtype GBM and 37.5% as not elsewhere classified. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1852por Tlemsani, Camille, Larousserie, Frédérique, De Percin, Sixtine, Audard, Virginie, Hadjadj, Djihad, Chen, Jeanne, Biau, David, Anract, Philippe, Terris, Benoit, Goldwasser, François, Pasmant, Eric, Boudou-Rouquette, Pascaline“…Central and peripheral CS differ at the molecular level with either IDH1/2 mutations or EXT1/2 mutations, respectively. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1853por Jucht, Alexander, Dumont, Sydney, Pooley, Channing, Gonzalez Castro, Luis Nicolas“…Diffusely infiltrating gliomas – including glioblastoma (GBM), isocitrate dehydrogenase (IDH) mutant gliomas, and histone 3 (H3) altered gliomas – are primary brain tumors with an invariably fatal outcome. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1854por Sierra Morales, Fabian, Wright, Robert B., Novo, Jorge E., Arvanitis, Leonidas D., Stefoski, Dusan, Koralnik, Igor J.“…One patient had an isocitrate dehydrogenase (IDH)‐wildtype GBM with aggressive behavior, who declined treatment and died 13 weeks after symptoms onset. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1855“…The literature review revealed that the most common genetic abnormalities in primary and secondary glioblastomas are IDH1 / 2 mutations, p53 mutations, and overexpression of EGFR. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1856“…Discoveries on recurrent and novel genetic mutations, such as FLT3-ITD and IDH1/IDH2, critical signaling pathways, and unique molecular markers expressed on the surface of leukemic cells have been under investigation for the management of R/R AML. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1857por Micaily, Ida, Roche, Megan, Ibrahim, Mohammad Y., Martinez-Outschoorn, Ubaldo, Mallick, Atrayee Basu“…This review focuses on metabolic changes in chondrosarcoma, and the relationship between signaling via isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2), hedgehog, PI3K-mTOR-AKT, and SRC, as well as histone acetylation and angiogenesis. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1858por Sfifou, Fatima, Ouzir, Mounir, Hakkou, El Mehdi, Obtel, Majdouline, Errihani, Hassan, Bouzidi, Abderrahmane Al, Abouqal, Redouane, Ouahabi, Abdessamad El, Cherradi, Nadia“…The data were presented, analyzed, and described in the article “Immunohistochemical expression of HIF-1α, IDH1 and TP53: prognostic profile of Moroccan patients with diffuse glioma” published in Journal of Chemical Neuroanatomy [1].…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1859por Obukhova, Larisa, Kopytova, Tatiana, Murach, Elena, Shchelchkova, Natalya, Kontorshchikova, Claudia, Medyanik, Igor, Orlinskaya, Natalia, Grishin, Artem, Kontorshchikov, Michael, Badanina, Dariya“…The most pronounced relationship with glutathione metabolism was demonstrated by the level of the nuclear protein Ki67 as a marker of proliferative activity, and the presence of the IDH1 mutation as one of the key genetic events of gliomagenesis. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1860